Utility of additional delayed post-therapeutic 131I whole-body scanning in patients with thyroid cancer

Clinical Nuclear Medicine

Volumn 37, Issue 3, 2012, Pages 264-267

  Kodani, Naohiro ^a   Okuyama, Chio ^a   Aibe, Norihiro ^a   Matsushima, Shigenori ^a   Yamazaki, Hideya ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

131I; Optimal time; Post therapeutic scanning; Thyroid cancer

Indexed keywords

IODINE 131;

ABDOMEN; ADOLESCENT; ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER PATIENT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LUNG METASTASIS; MALE; OUTCOME ASSESSMENT; SCHOOL CHILD; THYROID CANCER; THYROID GLAND; WHOLE BODY SCINTISCANNING;

ADOLESCENT; ADULT; AGED; BONE NEOPLASMS; CHILD; FEMALE; GAMMA CAMERAS; HUMANS; IODINE RADIOISOTOPES; LUNG NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; THYROID NEOPLASMS; TIME FACTORS; WHOLE BODY IMAGING;

EID: 84857215419     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3182444286     Document Type: Article

References (16)

1. Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167-1214.
2. Van Nostrand D. The benefits and risks of I-131 therapy in patients with well-differentiated thyroid cancer. Thyroid. 2009;19:1381-1391.
3. Fatourechi V, Hay ID, Mullan BP, et al. Are posttherapy radioiodine scans informative and do they influence subsequent therapy of patients with differentiated thyroid cancer? Thyroid. 2000;10:573-577. (Pubitemid 30670617)
4. Schlumberger M, Tubiana M, De Vathaire F, et al. Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab. 1986;63:960-967. (Pubitemid 16004302)
5. Casara D, Rubello D, Saladini G, et al. Distant metastases in differentiated thyroid cancer: long-term results of radioiodine treatment and statistical analysis of prognostic factors in 214 patients. Tumori. 1991;77:432-436.
6. Samaan NA, Schultz PN, Haynie TP, et al. Pulmonary metastasis of differentiated thyroid carcinoma: treatment results in 101 patients. J Clin Endocrinol Metab. 1985;60:376-380. (Pubitemid 15129587)
7. Mazzaferri EL, Kloos RT. Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab. 2001;86:1447-1463. (Pubitemid 32374886)
8. Chong A, Song HC, Min JJ, et al. Improved detection of lung or bone metastases with an I-131 whole body scan on the 7th day after high-dose I-131 therapy in patients with thyroid cancer. Nucl Med Mol Imaging. 2010;44:273-281.
9. Lee JW, Lee SM, Koh GP, et al. The comparison of 131I whole-body scans on the third and tenth day after 131I therapy in patients with well-differentiated thyroid cancer: preliminary report. Ann Nucl Med. 2011;25:139-146.
10. Hung BT, Huang SH, Huang YE, et al. Appropriate time for post-therapeutic I-131 whole body scan. Clin Nucl Med. 2009;34:339-342.
11. Cavalieri PR. Nuclear imaging in the management of thyroid carcinoma. Thyroid. 1996;6:485-492.
12. Grewal RK, Tuttle RM, Fox J, et al. The effect of posttherapy 131I SPECT/CT on risk classification and management of patients with differentiated thyroid cancer. J Nucl Med. 2010;51:1361-1367.
13. Casara D, Rubello D, Saladini G, et al. Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables. J Nucl Med. 1993;34:1626-1631. (Pubitemid 23295368)
14. Schlumberger M, Challeton C, De Vathaire F, et al. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med. 1996;37:598-605. (Pubitemid 126618447)
15. Bernier MO, Leenhardt L, Hoang C, et al. Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. J Clin Endocrinol Metab. 2001;86:1568-1573. (Pubitemid 32374905)
16. Durante C, Haddy N, Baudin E, et al. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab. 2006;91:2892-2899. (Pubitemid 44271732)